Website

Contact Information:

Michael Dieter
mdieter@seagen.com
(507) 301-1001

Kimberly Gibbons
kgibbons@seagen.com
(612) 281-7444

Virtual Exhibit Hall Home

Seagen Inc. is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development. For more information visit www.seagen.com.

Additional Information: 

PADCEV prescribing information

ADCETRIS prescribing information